Comprehensive non-correlated Cigna $CI Trading Report
Technical Summary
Term → | Near | Mid | Long |
---|---|---|---|
Rating | Weak | Strong | Neutral |
P1 | 0 | 0 | 155.28 |
P2 | 171.62 | 173.51 | 177.32 |
P3 | 175.61 | 178.85 | 197.20 |
Support and Resistance Plot Chart for CI
Long Term Trading Plans for CI
October 21, 2020, 3:30 am ET
The Technical Summary and Trading Plans for CI help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this CI Report.
CI - (Long) Support Plan
The technical summary data tells us to buy CI near 155.28 with an upside target of 177.32. This data also tells us to set a stop loss @ 154.83 to protect against excessive loss in case the stock begins to move against the trade. 155.28 is the first level of support below 171.09 , and by rule, any test of support is a buy signal. In this case, support 155.28 would be being tested, so a buy signal would exist.
CI - (Short) Resistance Plan
The technical summary data is suggesting a short of CI as it gets near 177.32 with a downside target of 155.28. We should have a stop loss in place at 177.83 though. 177.32 is the first level of resistance above 171.09, and by rule, any test of resistance is a short signal. In this case, if resistance 177.32 is being tested, so a short signal would exist.
Blue = Current Price
Red= Resistance
Green = Support
Real Time Updates for Repeat Institutional Readers:
Factset: Request User/Pass
Bloomberg, Reuters, Refinitiv, Zacks, or IB users: Access Here.
Our Market Crash Leading Indicator is Evitar Corte.
Evitar Corte warned of market crash risk four times since 2000.
It identified the Internet Debacle before it happened.
It identified the Credit Crisis before it happened.
It identified the Corona Crash too.
See what Evitar Corte is Saying Now.
Get Notified When our Ratings Change: Take a Trial